- NEWS AND VIEWS
A tumour-to-brain pathway hinders anticancer defences
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-026-00170-2
References
Padmanaban, V. et al. Nature 633, 207–215 (2024).
Zhi, X. et al. Nature 640, 802–810 (2025).
Winkler, F. et al. Cell 186, 1689–1707 (2023).
Wei, H. K. et al. Nature https://doi.org/10.1038/s41586-025-10028-8 (2026).
Blackwell, V. K., Van Goor, J. J. & Prescott, S. L. Cell Rep. 44, 116239 (2025).
de Visser, K. E. & Joyce, J. A. Cancer Cell 41, 374–403 (2023).
Balood, M. et al. Nature 611, 405–412 (2022).
Guyenet, P. G. et al. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R187–R204 (2013).
Abe, C. et al. Nature Neurosci. 20, 700–707 (2017).
Savchuk, S. et al. Nature 646, 1232–1242 (2025).
Sakthivelu, V. et al. Nature 646, 1243–1253 (2025).
Thiel, V. et al. Nature 640, 1042–1051 (2025).
Competing Interests
The authors declare no competing interests.
Read the paper: Tumour–brain crosstalk restrains cancer immunity via a sensory–sympathetic axis
Wired for growth: neuron–tumour signalling in the lung and brain increases growth of a hard-to-treat cancer
Brain tumours manipulate neighbouring synapses